Clinical Trial Update: A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating belinostat in combination with warfarin in patients with solid tumors or hematologic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Solid Tumor

Drugs mentioned

• BELEODAQ (BELINOSTAT)
• Warfarin (warfarin)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Solid Tumor, Hematological Malignancy | Phase 1 | Status: COMPLETED